FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/04/108679 [Registered on: 20/04/2026] Trial Registered Prospectively
Last Modified On: 17/04/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A Comparative Clinical Study To Evaluate The Effect Of Vataraktanashak Yoga And Kaishora Guggulu In Patients Of Hyperuricemia 
Scientific Title of Study   An Open-Label, Randomised, Comparative Clinical Study to Evaluate the Efficacy of Vataraktanashak Yoga and Kaishora Guggulu in the Management of Vatarakta with Special Reference to Hyperuricemia (Gout). 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Yash Nana Rathod 
Designation  PG Scholar 
Affiliation  APMS ayurved mahavidyalaya,sion 
Address  Department of Kayachikitsa, 4th floor, APMS Ayurved Mahavidyalaya, near Sion railway station, Sion East, Mumbai 22 Mumbai MAHARASHTRA 400022 India 

Mumbai
MAHARASHTRA
400022
India 
Phone  9834339988  
Fax    
Email  dryashrathod018@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Yash Nana Rathod 
Designation  PG Scholar 
Affiliation  APMS ayurved mahavidyalaya,sion 
Address  Department of Kayachikitsa, 4th floor, APMS Ayurved Mahavidyalaya, near Sion railway station, Sion East, Mumbai 22 Mumbai MAHARASHTRA 400022 India 


MAHARASHTRA
400022
India 
Phone  9834339988  
Fax    
Email  dryashrathod018@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Hemant Shridhar Paradkar 
Designation  Associate Proffesor 
Affiliation  APMS ayurved mahavidyalay,sion 
Address  Department of Kayachikitsa, 4th floor, APMS Ayurved Mahavidyalaya, near Sion railway station, Sion East, Mumbai 22 Mumbai MAHARASHTRA 400022 India 

Mumbai
MAHARASHTRA
400022
India 
Phone  9834339988  
Fax    
Email  hemant.paradkar@gmail.com  
 
Source of Monetary or Material Support  
APMs Ayurved Mahavidyalaya,Seth R V Ayurvedic hospital,sion ,near sion railwa station,Sion East ,Mumbai ,Maharasthtra,India  
 
Primary Sponsor  
Name  Seth RV Ayurved Hospital 
Address  Near sion railway station,sion east,mumbai 400022 
Type of Sponsor  Other [(charitable ayurvedic hospital)] 
 
Details of Secondary Sponsor  
Name  Address 
nil   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Yash Nana Rathod  Seth RV Ayurvedic Hospital  Department of Kayachikitsa, 4th floor, APMS Ayurved Mahavidyalaya, near Sion railway station, Sion East, Mumbai 22 Mumbai MAHARASHTRA 400022 India 
Mumbai
MAHARASHTRA 
9834339988

dryashrathod018@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
APM AYURVED MAHAVIDYALAYA SION  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M109||Gout, unspecified. Ayurveda Condition: VATARAKTAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugOther than Classical(1) Medicine Name: Vataraktanashak yoga, Reference: NA, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/Tablets, Dose: 1000(mg), Frequency: bd, Bhaishajya Kal: Antarabhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: lukeworm water), Additional Information: -administered orally for 45 days with lukewarm water
2Comparator ArmDrugClassical(1) Medicine Name: Kaishora guggule, Reference: bhaishajya ratnavali, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 1000(mg), Frequency: bd, Bhaishajya Kal: Antarabhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: -lukeworm water), Additional Information: -
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Patients aged between 25 to 70 years.
Both male and female patients.
Clinically diagnosed cases of Vatarakta.
Serum uric acid: Males 7 to 12 mg per dL and Females 6 to 12 mg per dL.
Presence of at least two symptoms such as joint pain, swelling, stiffness, tenderness, or burning sensation 
 
ExclusionCriteria 
Details  Chronic renal failure.
Pregnant and lactating women.
Rheumatoid arthritis.
HIV or HBsAg positive patients.
Chronic alcoholism.
Peripheral vascular disease. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Change in serum uric acid level from baseline to Day 45 and reduction in clinical symptoms such as joint pain, swelling, stiffness, tenderness, and burning sensation.
 
baseline and day 45
 
 
Secondary Outcome  
Outcome  TimePoints 
Reduction in use of rescue medication, improvement in patient quality of life, and assessment of adverse events.  Baseline,day45,and during follow up if applicable 
improvement in clinical symptoms of vatarakta  baseline and day 45 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   11/05/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This study is an open label randomized comparative clinical trial designed to evaluate the efficacy of Vataraktanashak Yoga and Kaishora Guggulu in the management of Vatarakta with special reference to gout. A total of 80 patients fulfilling the inclusion criteria will be randomly allocated into two groups with 40 patients in each group. Group A will receive Vataraktanashak Yoga and Group B will receive Kaishora Guggulu for a duration of 45 days. The primary outcome measures include change in serum uric acid levels and improvement in clinical symptoms such as joint pain, swelling, stiffness, tenderness and burning sensation. The study aims to evaluate the comparative effectiveness and safety of both interventions in the management of gout.

 
Close